
Interventional Neuroradiology Global Market Report 2025
Description
Interventional Neuroradiology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on interventional neuroradiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for interventional neuroradiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The interventional neuroradiology market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Device Type: Microcatheters; Neurovascular Embolization And Coiling Assist Devices; Embolic Coils; Flow Diversion Devices; Liquid Embolic Agents; Accessories; Micro Guidewires
2) By Disease: Cerebral Aneurysms; Intra-Cranial Tumors; Acute Strokes; Other Diseases
3) By End Users: Hospitals; Ambulatory Surgical Centers; Diagnostic Centers
Subsegments:
1) By Microcatheters: Single-Lumen Microcatheters; Dual-Lumen Microcatheters; High-Flow Microcatheters
2) By Neurovascular Embolization And Coiling Assist Devices: Coiling Assist Devices; Embolization Assist Devices
3) By Embolic Coils: Soft Coils; Stiff Coils; Detachable Coils
4) By Flow Diversion Devices: Stent-Based Flow Diversion Devices; Non-Stent-Based Flow Diversion Devices
5) By Liquid Embolic Agents: Polymer-Based Liquid Embolic Agents; Gel-Based Liquid Embolic Agents; Onyx Liquid Embolic Agents
6) By Accessories: Guide Catheters; Sheath Introducers; Vascular Access Devices
7) By Micro Guidewires: Hydrophilic Micro Guidewires; Pushable Micro Guidewires; Coated Micro Guidewires
Companies Mentioned: Bayer HealthCare; Abbott Laboratories; Medtronic PLC; Siemens Healthineers AG; Fujifilm Corporation; Philips Healthcare; Stryker Corporation; GE Healthcare Life Sciences; Boston Scientific Corporation; Terumo Corporation; Canon Medical Systems Corporation; W. L. Gore & Associates Inc.; Teleflex Incorporated; Cook Medical LLC; Biotronik SE & Co. KG; Merit Medical Systems Inc.; MicroPort Scientific Corporation; Penumbra Inc.; Guerbet Group; Mediterra LLC; Acandis GmbH; Medico's Hirata Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on interventional neuroradiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for interventional neuroradiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The interventional neuroradiology market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Device Type: Microcatheters; Neurovascular Embolization And Coiling Assist Devices; Embolic Coils; Flow Diversion Devices; Liquid Embolic Agents; Accessories; Micro Guidewires
2) By Disease: Cerebral Aneurysms; Intra-Cranial Tumors; Acute Strokes; Other Diseases
3) By End Users: Hospitals; Ambulatory Surgical Centers; Diagnostic Centers
Subsegments:
1) By Microcatheters: Single-Lumen Microcatheters; Dual-Lumen Microcatheters; High-Flow Microcatheters
2) By Neurovascular Embolization And Coiling Assist Devices: Coiling Assist Devices; Embolization Assist Devices
3) By Embolic Coils: Soft Coils; Stiff Coils; Detachable Coils
4) By Flow Diversion Devices: Stent-Based Flow Diversion Devices; Non-Stent-Based Flow Diversion Devices
5) By Liquid Embolic Agents: Polymer-Based Liquid Embolic Agents; Gel-Based Liquid Embolic Agents; Onyx Liquid Embolic Agents
6) By Accessories: Guide Catheters; Sheath Introducers; Vascular Access Devices
7) By Micro Guidewires: Hydrophilic Micro Guidewires; Pushable Micro Guidewires; Coated Micro Guidewires
Companies Mentioned: Bayer HealthCare; Abbott Laboratories; Medtronic PLC; Siemens Healthineers AG; Fujifilm Corporation; Philips Healthcare; Stryker Corporation; GE Healthcare Life Sciences; Boston Scientific Corporation; Terumo Corporation; Canon Medical Systems Corporation; W. L. Gore & Associates Inc.; Teleflex Incorporated; Cook Medical LLC; Biotronik SE & Co. KG; Merit Medical Systems Inc.; MicroPort Scientific Corporation; Penumbra Inc.; Guerbet Group; Mediterra LLC; Acandis GmbH; Medico's Hirata Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
250 Pages
- 1. Executive Summary
- 2. Glaucoma Market Characteristics
- 3. Glaucoma Market Trends And Strategies
- 4. Glaucoma Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
- 5. Global Glaucoma Growth Analysis And Strategic Analysis Framework
- 5.1. Global Glaucoma PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Glaucoma Market Growth Rate Analysis
- 5.4. Global Glaucoma Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Glaucoma Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Glaucoma Total Addressable Market (TAM)
- 6. Glaucoma Market Segmentation
- 6.1. Global Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Open Angle Glaucoma
- Angle Closure Glaucoma
- Other Disease Types
- 6.2. Global Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tonometry
- Ophthalmoscopy
- Perimetry
- Gonioscopy
- 6.3. Global Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Beta Blockers
- Prostaglandins
- Alpha Adrenergic Agonist
- Carbonic Anhydrase Inhibitors
- Combination Drugs
- Other Drug Classes
- 6.4. Global Glaucoma Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Injections
- Intravitreal
- Other Administrations
- 6.5. Global Glaucoma Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Ophthalmic Clinics
- Ambulatory Surgical Centers
- 6.6. Global Glaucoma Market, Sub-Segmentation Of Open Angle Glaucoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Primary Open Angle Glaucoma (POAG)
- Secondary Open Angle Glaucoma
- 6.7. Global Glaucoma Market, Sub-Segmentation Of Angle Closure Glaucoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Primary Angle Closure Glaucoma
- Secondary Angle Closure Glaucoma
- 6.8. Global Glaucoma Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Normal-Tension Glaucoma
- Pigmentary Glaucoma
- Pseudoexfoliative Glaucoma
- Congenital Glaucoma
- 7. Glaucoma Market Regional And Country Analysis
- 7.1. Global Glaucoma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Glaucoma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Glaucoma Market
- 8.1. Asia-Pacific Glaucoma Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Glaucoma Market
- 9.1. China Glaucoma Market Overview
- 9.2. China Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Glaucoma Market
- 10.1. India Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Glaucoma Market
- 11.1. Japan Glaucoma Market Overview
- 11.2. Japan Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Glaucoma Market
- 12.1. Australia Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Glaucoma Market
- 13.1. Indonesia Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Glaucoma Market
- 14.1. South Korea Glaucoma Market Overview
- 14.2. South Korea Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Glaucoma Market
- 15.1. Western Europe Glaucoma Market Overview
- 15.2. Western Europe Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Glaucoma Market
- 16.1. UK Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Glaucoma Market
- 17.1. Germany Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Glaucoma Market
- 18.1. France Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Glaucoma Market
- 19.1. Italy Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Glaucoma Market
- 20.1. Spain Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Glaucoma Market
- 21.1. Eastern Europe Glaucoma Market Overview
- 21.2. Eastern Europe Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Glaucoma Market
- 22.1. Russia Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Glaucoma Market
- 23.1. North America Glaucoma Market Overview
- 23.2. North America Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Glaucoma Market
- 24.1. USA Glaucoma Market Overview
- 24.2. USA Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Glaucoma Market
- 25.1. Canada Glaucoma Market Overview
- 25.2. Canada Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Glaucoma Market
- 26.1. South America Glaucoma Market Overview
- 26.2. South America Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Glaucoma Market
- 27.1. Brazil Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Glaucoma Market
- 28.1. Middle East Glaucoma Market Overview
- 28.2. Middle East Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Glaucoma Market
- 29.1. Africa Glaucoma Market Overview
- 29.2. Africa Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Glaucoma Market Competitive Landscape And Company Profiles
- 30.1. Glaucoma Market Competitive Landscape
- 30.2. Glaucoma Market Company Profiles
- 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Teva Pharmaceuticals Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 31. Glaucoma Market Other Major And Innovative Companies
- 31.1. Otsuka Pharmaceutical Co. Ltd.
- 31.2. Sun Pharmaceutical Industries Ltd.
- 31.3. Cipla Limited
- 31.4. Bausch & Lomb Corp.
- 31.5. Carl Zeiss Meditec
- 31.6. Santen Pharmaceuticals Co. Ltd.
- 31.7. Topcon Corporation
- 31.8. Thea Laboratoires
- 31.9. Corza Ophthalmology
- 31.10. Lumenis Ltd.
- 31.11. Alcon Inc.
- 31.12. Viva BioInnovator
- 31.13. Glaukos Corporation
- 31.14. Iridex Corporation
- 31.15. Nova Eye Medical Ltd.
- 32. Global Glaucoma Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Glaucoma Market
- 34. Recent Developments In The Glaucoma Market
- 35. Glaucoma Market High Potential Countries, Segments and Strategies
- 35.1 Glaucoma Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Glaucoma Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Glaucoma Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.